动物医学进展
動物醫學進展
동물의학진전
PROGRESS IN VETERINARY MEDICINE
2013年
12期
69-73
,共5页
肖跃强%谢金文%徐二丹%沈志强%丁壮
肖躍彊%謝金文%徐二丹%瀋誌彊%丁壯
초약강%사금문%서이단%침지강%정장
兔出血症病毒%实时荧光定量逆转录-聚合酶链反应%建立
兔齣血癥病毒%實時熒光定量逆轉錄-聚閤酶鏈反應%建立
토출혈증병독%실시형광정량역전록-취합매련반응%건립
Rabbit haemorrhagic disease virus%real-time RT-PCR%establishment
为建立一种敏感、特异、简便的兔出血症病毒(RHDV)检测方法,根据 GenBank 中公布的RHDV 全基因组序列保守区域设计了2对引物,筛选了其中1对建立并优化了 PCR 条件,扩增产物为331 bp,并基于此建立了 SYBR Green Ⅰ荧光染料 real-time RT-PCR 检测方法。通过敏感性、特异性、标准曲线建立等表明,该方法可检出101以上拷贝数的模板,只在 RHDV 有特异性扩增,标准曲线线性相关性好。实际应用结果显示,该方法对疑似 RHDV 病料检测的阳性率为74.8%,而普通 RT-PCR 方法检测的阳性率为65.5%。该方法的建立为开展该病的诊断、疫苗制备质控等提供了有效的技术保障。
為建立一種敏感、特異、簡便的兔齣血癥病毒(RHDV)檢測方法,根據 GenBank 中公佈的RHDV 全基因組序列保守區域設計瞭2對引物,篩選瞭其中1對建立併優化瞭 PCR 條件,擴增產物為331 bp,併基于此建立瞭 SYBR Green Ⅰ熒光染料 real-time RT-PCR 檢測方法。通過敏感性、特異性、標準麯線建立等錶明,該方法可檢齣101以上拷貝數的模闆,隻在 RHDV 有特異性擴增,標準麯線線性相關性好。實際應用結果顯示,該方法對疑似 RHDV 病料檢測的暘性率為74.8%,而普通 RT-PCR 方法檢測的暘性率為65.5%。該方法的建立為開展該病的診斷、疫苗製備質控等提供瞭有效的技術保障。
위건립일충민감、특이、간편적토출혈증병독(RHDV)검측방법,근거 GenBank 중공포적RHDV 전기인조서렬보수구역설계료2대인물,사선료기중1대건립병우화료 PCR 조건,확증산물위331 bp,병기우차건립료 SYBR Green Ⅰ형광염료 real-time RT-PCR 검측방법。통과민감성、특이성、표준곡선건립등표명,해방법가검출101이상고패수적모판,지재 RHDV 유특이성확증,표준곡선선성상관성호。실제응용결과현시,해방법대의사 RHDV 병료검측적양성솔위74.8%,이보통 RT-PCR 방법검측적양성솔위65.5%。해방법적건립위개전해병적진단、역묘제비질공등제공료유효적기술보장。
To establish a sensitive,specific and simple diagnosis method for RHDV,2 pairs of primers were designed according to the conservative sequences of rabbit haemorrhagic disease virus(RHDV)published in GenBank,and one pair of them was screened and the reaction system of PCR was optimized,by which a real-time RT-PCR was established based on SYBR Green I fluorescent dye.This method was much more sensitive and specific,a minimum of 101 copies of viral cDNA or more could be detected,only RHDV was detectable among RHDV,rabbit rotavirus and rabbit vesicular stomatitis virus.A standard curve with high linear correlation was also established.The application results showed that the positive detectable ratio of the real-time RT-PCR was 74.8%,but only 65.5% with the RT-PCR.This real-time PCR can be used for diagnosis of RHD and quality control for vaccine production.